Discover how groundbreaking research reveals EGFR and HER2 contribute equally to breast cancer signaling pathways in human mammary epithelial cells.
Explore how 99mTc-labeled anti-EGFR antibodies are revolutionizing cancer imaging through targeted nuclear medicine approaches.